Thomas Dorothy A, Huang Anne, McCarron Michelle C E, Kappel Joanne E, Holden Rachel M, Yeates Karen E, Richardson Bonnie R
Division of Nephrology, Department of Medicine, Queen's University, Kingston, ON, Canada.
First Nations and Inuit Health, Health Canada, Saskatoon, SK, Canada.
Can J Kidney Health Dis. 2018 Sep 17;5:2054358118799689. doi: 10.1177/2054358118799689. eCollection 2018.
Chronic kidney disease is more prevalent among First Nations people than in non-First Nations people. Emerging research suggests that First Nations people are subject to greater disease burden than non-First Nations people.
We aimed to identify the severity of chronic kidney disease and quantify the geographical challenges of obtaining kidney care by Saskatchewan's First Nations people.
This study is a retrospective analysis of the provincial electronic medical record clinical database from January 2012 to December 2013.
The setting involved patients followed by the Saskatchewan provincial chronic kidney care program, run out of two clinics, one in Regina, SK, and one in Saskatoon, SK.
The patients included 2478 individuals (379 First Nations and 2099 non-First Nations) who were older than 18 years old, resident in Saskatchewan, and followed by the provincial chronic kidney care program. First Nations individuals were identified by their Indigenous and Northern Affairs Canada (INAC) Number.
The demographics, prevalence, cause of end-stage renal disease, severity of chronic kidney disease, use of home-based therapies, and distance traveled for care among patients are reported.
Data were extracted from the clinical database used for direct patient care (the provincial electronic medical record database for the chronic kidney care program), which is prospectively managed by the health care staff. Actual distance traveled by road for each patient was estimated by a Geographic Information System Analyst in the First Nations and Inuit Health Branch of Health Canada.
Compared with non-First Nations, First Nations demonstrate a higher proportion of end-stage renal disease (First Nations = 33.0% vs non-First Nations = 21.4%, < .001), earlier onset of chronic kidney disease (M = 56.4 years, SD = 15.1; M = 70.6 years, SD = 14.7, < .001), and higher rates of end-stage renal disease secondary to type 2 diabetes (First Nations = 66.1% vs non-First Nations = 39.0%, < .001). First Nations people are also more likely to be on dialysis (First Nations = 69.7% vs non-First Nations = 40.2%, < .001), use home-based therapies less frequently (First Nations = 16.2% vs non-First Nations = 25.7%; = 003), and must travel farther for treatment ( < .001), with First Nations being more likely than non-First Nations to have to travel greater than 200 km.
Patients who are followed by their primary care provider or solely through their nephrologist's office for their chronic kidney disease would not be included in this study. Patients who self-identify as Aboriginal or Indigenous without an INAC number would not be captured in the First Nations cohort.
In Saskatchewan, First Nations' burden of chronic kidney disease reveals higher severity, utilization of fewer home-based therapies, and longer travel distances than their non-First Nations counterparts. More research is required to identify innovative solutions within First Nations partnering communities.
慢性肾脏病在原住民中比在非原住民中更为普遍。新出现的研究表明,原住民比非原住民承受着更大的疾病负担。
我们旨在确定慢性肾脏病的严重程度,并量化萨斯喀彻温省原住民获得肾脏护理的地理挑战。
本研究是对2012年1月至2013年12月省级电子病历临床数据库的回顾性分析。
研究对象为参加萨斯喀彻温省慢性肾脏病护理项目的患者,该项目在两个诊所开展,一个位于萨斯喀彻温省的里贾纳,另一个位于萨斯卡通。
患者包括2478名18岁以上、居住在萨斯喀彻温省且参加省级慢性肾脏病护理项目的个体(379名原住民和2099名非原住民)。原住民个体通过其加拿大原住民和北方事务部(INAC)编号识别。
报告了患者的人口统计学特征、患病率、终末期肾病病因、慢性肾脏病严重程度、家庭治疗的使用情况以及就医的行程距离。
数据从用于直接患者护理的临床数据库(慢性肾脏病护理项目的省级电子病历数据库)中提取,该数据库由医护人员进行前瞻性管理。加拿大卫生部原住民和因纽特人健康处的地理信息系统分析师估算了每位患者实际的公路行程距离。
与非原住民相比,原住民的终末期肾病比例更高(原住民 = 33.0%,非原住民 = 21.4%,P <.001),慢性肾脏病发病更早(中位数 = 56.4岁,标准差 = 15.1;中位数 = 70.6岁,标准差 = 14.7,P <.001),2型糖尿病继发的终末期肾病发生率更高(原住民 = 66.1%,非原住民 = 39.0%,P <.001)。原住民也更有可能接受透析(原住民 = 69.7%,非原住民 = 40.2%,P <.001),较少使用家庭治疗(原住民 = 16.2%,非原住民 = 25.7%;P = 0.003),且就医行程更远(P <.001),原住民比非原住民更有可能行程超过200公里。
由初级保健提供者随访或仅通过肾病科医生办公室随访慢性肾脏病的患者不包括在本研究中。自我认定为原住民但没有INAC编号的患者不会被纳入原住民队列。
在萨斯喀彻温省,与非原住民相比,原住民的慢性肾脏病负担显示出更高的严重程度、更少使用家庭治疗以及更长的行程距离。需要更多研究来确定在原住民合作社区内的创新解决方案。